Patients To protect sciences and pharma in an RFK Jr era, put consume... During election cycles, much is made of policy positions on the economy, immigration, foreign affairs, etc. However, rarely is attention paid to the policy of science.
Patients Why language training is crucial for healthcare teams In today's increasingly globalised world, multilingualism and cultural diversity have become fundamental aspects of modern life.
Oncology Words matter: The power of language in cancer discussions The priority for any individual diagnosed with cancer is to be provided an effective therapy as quickly as possible.
Views & Analysis Words, inclusivity, and the struggle for health equality Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face